Nanometrics to Announce First Quarter Financial Results on April 26, 2016
Apr 05, 2016 20:05 pm UTC| Business
MILPITAS, Calif., April 05, 2016 -- Nanometrics Incorporated (NASDAQ:NANO), a leading provider of advanced process control systems, will release its first quarter financial results after market close on April 26, 2016....
TRACON Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference
Apr 05, 2016 20:05 pm UTC| Business
SAN DIEGO, April 05, 2016 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
Johnson Outdoors Acquires Assets of Northport Systems
Apr 05, 2016 20:03 pm UTC| Business
RACINE, Wis., April 05, 2016 -- Johnson Outdoors Inc. (NASDAQ:JOUT) today announced the acquisition of the key assets of Northport Systems, Inc., specialists in the development and application of unique digital...
Bermuda is different: BDA responds to Panama Papers
Apr 05, 2016 20:02 pm UTC| Business
HAMILTON, Bermuda, April 05, 2016 -- Some of the recent reporting on the “Panama Papers” perpetuates the myth that all offshore financial centres are the same. The fact is: Bermuda is different. While there may be...
The Shelter Pet Project to Ring The Nasdaq Stock Market Closing Bell
Apr 05, 2016 20:02 pm UTC| Business
ADVISORY, April 05, 2016 -- What:Representatives from The Shelter Pet Project will visit the Nasdaq MarketSite in Times Square. The Shelter Pet Project, a collaborative effort between the Ad Council and two leading...
Pernix Therapeutics to Present at Needham & Company’s 15th Annual Healthcare Conference
Apr 05, 2016 20:01 pm UTC| Business
MORRISTOWN, N.J., April 05, 2016 -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman and Chief Executive Officer, and Sanjay Patel, Chief...
KemPharm to Present at the Needham & Company’s 15th Annual Healthcare Conference in New York, NY
Apr 05, 2016 20:01 pm UTC| Business
CORALVILLE, Iowa, April 05, 2016 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that its president...